139 related articles for article (PubMed ID: 6819280)
1. The myxovirescins, a family of antibiotics from Myxococcus virescens (Myxobacterales).
Gerth K; Irschik H; Reichenbach H; Trowitzsch W
J Antibiot (Tokyo); 1982 Nov; 35(11):1454-9. PubMed ID: 6819280
[TBL] [Abstract][Full Text] [Related]
2. The myxovalargins, new peptide antibiotics from Myxococcus fulvus (Myxobacterales). I. Cultivation, isolation, and some chemical and biological properties.
Irschik H; Gerth K; Kemmer T; Steinmetz H; Reichenbach H
J Antibiot (Tokyo); 1983 Jan; 36(1):6-12. PubMed ID: 6432761
[TBL] [Abstract][Full Text] [Related]
3. A macrocyclic antibiotic M-230B produced by Myxococcus xanthus. Isolation and characterization.
Onishi N; Izaki K; Takahashi H
J Antibiot (Tokyo); 1984 Jan; 37(1):13-9. PubMed ID: 6421789
[TBL] [Abstract][Full Text] [Related]
4. Production, isolation, physico-chemical and biological properties of angiolam A, a new antibiotic from Angiococcus disciformis (Myxobacterales).
Kunze B; Kohl W; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1985 Dec; 38(12):1649-54. PubMed ID: 3937837
[TBL] [Abstract][Full Text] [Related]
5. The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales).
Irschik H; Gerth K; Höfle G; Kohl W; Reichenbach H
J Antibiot (Tokyo); 1983 Dec; 36(12):1651-8. PubMed ID: 6420386
[TBL] [Abstract][Full Text] [Related]
6. Purification and partial characterization of an antibiotic produced by Myxococcus xanthus.
Vaks B; Zuckerberg A; Rosenberg E
Can J Microbiol; 1974 Feb; 20(2):155-61. PubMed ID: 4362757
[No Abstract] [Full Text] [Related]
7. Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties.
Gerth K; Irschik H; Reichenbach H; Trowitzsch W
J Antibiot (Tokyo); 1980 Dec; 33(12):1474-9. PubMed ID: 6788741
[TBL] [Abstract][Full Text] [Related]
8. The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales). I. Production, physico-chemical and biological properties, and mechanism of action.
Gerth K; Jansen R; Reifenstahl G; Höfle G; Irschik H; Kunze B; Reichenbach H; Thierbach G
J Antibiot (Tokyo); 1983 Sep; 36(9):1150-6. PubMed ID: 6415031
[TBL] [Abstract][Full Text] [Related]
9. Novel macrocyclic antibiotics: megovalicins A, B, C, D, G and H. II. Isolation and chemical structures of megovalicins.
Takayama S; Yamanaka S; Miyashiro S; Yokokawa Y; Shibai H
J Antibiot (Tokyo); 1988 Apr; 41(4):439-45. PubMed ID: 3131290
[TBL] [Abstract][Full Text] [Related]
10. Stigmatellin, a new antibiotic from Stigmatella aurantiaca (Myxobacterales). I. Production, physico-chemical and biological properties.
Kunze B; Kemmer T; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1984 May; 37(5):454-61. PubMed ID: 6429114
[TBL] [Abstract][Full Text] [Related]
11. The tartrolons, new boron-containing antibiotics from a myxobacterium, Sorangium cellulosum.
Irschik H; Schummer D; Gerth K; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1995 Jan; 48(1):26-30. PubMed ID: 7532644
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal action of an antibiotic produced by Myxococcus xanthus.
Rosenberg E; Vaks B; Zuckerberg A
Antimicrob Agents Chemother; 1973 Nov; 4(5):507-13. PubMed ID: 4208901
[TBL] [Abstract][Full Text] [Related]
13. Myxovirescin analogues via macrocyclic ring-closing metathesis.
Content S; Dutton CJ; Roberts L
Bioorg Med Chem Lett; 2003 Feb; 13(3):321-5. PubMed ID: 12565921
[TBL] [Abstract][Full Text] [Related]
14. Biological activity of an antibiotic produced by Myxococcus coralloides.
Arias JM; Rodriguez C; Montoya E
Microbios; 1979; 24(96):123-31. PubMed ID: 120482
[TBL] [Abstract][Full Text] [Related]
15. Saframycin Mx1, a new natural saframycin isolated from a myxobacterium.
Irschik H; Trowitzsch-Kienast W; Gerth K; Höfle G; Reichenbach H
J Antibiot (Tokyo); 1988 Aug; 41(8):993-8. PubMed ID: 2459096
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic activity of myxobacteria in relation to their bacteriolytic capacity.
NOREN B; RAPER KB
J Bacteriol; 1962 Jul; 84(1):157-62. PubMed ID: 14480333
[TBL] [Abstract][Full Text] [Related]
17. The primary structure of fulvocin C from Myxococcus fulvus.
Tsai H; Hirsch HJ
Biochim Biophys Acta; 1981 Jan; 667(1):213-7. PubMed ID: 6783114
[TBL] [Abstract][Full Text] [Related]
18. Malioxamycin, a new antibiotic with spheroplast-forming activity. I. Producing organism, fermentation, isolation and characterization.
Takeuchi M; Inukai M; Enokita R; Iwado S; Takahashi S; Arai M
J Antibiot (Tokyo); 1980 Nov; 33(11):1213-9. PubMed ID: 7019175
[TBL] [Abstract][Full Text] [Related]
19. Corallorazines from the myxobacterium Corallococcus coralloides.
Schmitz A; Kehraus S; Schäberle TF; Neu E; Almeida C; Roth M; König GM
J Nat Prod; 2014 Jan; 77(1):159-63. PubMed ID: 24422674
[TBL] [Abstract][Full Text] [Related]
20. Novel macrocyclic antibiotics: megovalicins A, B, C, D, G and H. I. Screening of antibiotics-producing myxobacteria and production of megovalicins.
Miyashiro S; Yamanaka S; Takayama S; Shibai H
J Antibiot (Tokyo); 1988 Apr; 41(4):433-8. PubMed ID: 3131289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
